FDA Inspection 1275077 — Maria Mazurkiewicz-Beldzinska, M.D. PhD
The FDA completed an inspection of Maria Mazurkiewicz-Beldzinska, M.D. PhD on Jun 25, 2025 in Gdansk. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Jun 25, 2025
- Fiscal Year
- 2025
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Gdansk (Poland)
Additional Details
Clinical Investigator (CI)